A Comparison of Fluticasone Propionate, 100??g Twice Daily, Administered Via a CFC and Non-CFC Propellant, HFA 134a, in Adult Patients with Asthma
- 1 January 2001
- journal article
- Published by Springer Nature in Clinical Drug Investigation
- Vol. 21 (10) , 695-703
- https://doi.org/10.2165/00044011-200121100-00004
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Efficacy response of inhaled beclomethasone dipropionate in asthma is proportional to dose and is improved by formulation with a new propellantJournal of Allergy and Clinical Immunology, 1999
- Comparative Efficacy and Safety of Twice Daily Fluticasone Propionate Powder Versus Placebo in the Treatment of Moderate AsthmaAnnals of Allergy, Asthma & Immunology, 1997
- Effectiveness of fluticasone propionate in patients with moderate asthma: a dose-ranging studyClinical Therapeutics, 1996
- Assessing equivalence of inhaled drugsRespiratory Medicine, 1995
- GR106642X: a new, non-ozone depleting propellant for inhalersBMJ, 1995
- Fluticasone propionate aerosol for the treatment of adults with mild to moderate asthmaJournal of Allergy and Clinical Immunology, 1994
- Metered-dose inhalers and CFCs: what respiratory physicians need to knowRespiratory Medicine, 1994
- CFCs and inhalersThe Lancet, 1994
- Nimbus 7 satellite measurements of the springtime Antarctic ozone decreaseNature, 1986
- Large losses of total ozone in Antarctica reveal seasonal ClOx/NOx interactionNature, 1985